Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jan 12;15(1):e33701.
doi: 10.7759/cureus.33701. eCollection 2023 Jan.

Para Kala-Azar Dermal Leishmaniasis: A Case Report

Md Moniruzzaman  1 , S K Jakaria Been Sayeed  1 , Md Abdur Rahim  2 , Rashedul Hassan  3 , Md Mujibur Rahman  4
Affiliations
Case Reports

Para Kala-Azar Dermal Leishmaniasis: A Case Report

Md Moniruzzaman et al. Cureus. .

Abstract

Rarely, post-kala-azar dermal leishmaniasis (PKDL) may coexist with visceral leishmaniasis (VL). The concomitant PKDL and VL are referred to as Para-kala-azar dermal Leishmaniasis. We report a case of Para kala-azar dermal leishmaniasis in a chronic Hepatitis-B virus-infected patient who presented with an abdominal lump and multiple maculopapular skin lesions and is resistant to sodium stibogluconate but successfully treated with liposomal Amphotericin-B.

Keywords: leishmania donovani; liposomal amphotericin b; para kala-azar; post kala-azar dermal leishmaniasis; visceral leishmaniasis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. multiple hypo and hyper pigmented macular and maculopapular non-scaly skin lesions present all over the body, mostly on the back and abdomen (yellow arrow)
Figure 2
Figure 2. Liver biopsy shows presence of Leismania donovani (LD) bodies in macrophage (yellow arrow)
See this image and copyright information in PMC

References

    1. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Br J Dermatol. 2000;143:136–143. - PubMed
    1. Post-kala-azar dermal Leishmaniasis, review. Zijlstra EE, Musa AM, Khalil EAG, El Hassan IM, and El-Hassan AM. Lancet Infect Dis. 2003;3:87–98. - PubMed
    1. Distinguishing post-kala-azar dermal leishmaniasis from leprosy: experience in the Sudan. el Hassan AM, Hashim FA, Abdullah M, Zijlstra EE, Ghalib HW. Lepr Rev. 1993;64:53–59. - PubMed
    1. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation. Rijal A, Agrawal S, Agarwalla A, Agrawal A, Rijal S. Int J Dermatol. 2005;44:494–496. - PubMed
    1. Kala azar with disseminated dermal leishmaniasis. Kumar PV, Sadeghi E, Torabi S. Am J Trop Med Hyg. 1989;40:150–153. - PubMed

Publication types

LinkOut - more resources